Lauren J. Evans
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lauren J. Evans has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Becca Xie
Department of Neuroscience, School of Translational Medicine, Monash University, Victoria, Australia
3 shared publications - Biswadev Mitra
School of Public Health and Preventive Medicine Monash University Melbourne Victoria Australia
3 shared publications - James W. Hickey
Monash University, Department of Neuroscience, School of Translational Medicine, Melbourne, Victoria, 3004, Australia
3 shared publications - Lauren P. Giesler
Department of Neuroscience, School of Translational Medicine, Monash University, Victoria, Australia
3 shared publications - Sandy R. Shultz
Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia
3 shared publications - Stuart John McDonald
Department of Neuroscience, School of Translational Medicine Monash University Melbourne Victoria Australia
3 shared publications
Latest Publications
- Open Access
- 16 February 2026
- Published by Springer Nature in Sports Medicine - Open
- Vol. 12 (1) , 11
Head Acceleration Events Measured by Instrumented Mouthguards in Elite Australian Football
The consequences of exposure to head acceleration events (HAEs) in collision sports, including Australian Rules football, are a growing concern. Instrumented mouthguards (iMGs) now enable accurate quantification of HAEs in sport; however, little is known about HAE incidence and mechanisms in Australian Rules football. We aimed to measure HAEs in elite Australian Rules football players, and evaluate the influence of playing position and match event on the incidence and magnitude of HAEs in men and women. iMG data were collected from Australian Football League (AFL) and AFL Women's (AFLW) players in 2023 utilising the HIT-IQ Nexus Gen III iMG, targeting 500 player-matches per sex. Match footage was synchronised with iMG data for video verification and match play coding. Three hundred and eleven players contributed iMG data in the analyses, including 126 men (median matches per player: 3 (interquartile range [IQR: 2-6]) and 185 women (median: 3 [IQR: 1-4]). Men had a higher mean incidence of HAEs ≥ 8 g per match than women (5.7 [95% confidence interval CI: 5.0-6.4] vs. 3.0 [95% CI: 2.8-3.3]), however the incidence was comparable when adjusted for time (3.6/hour [95% CI: 3.2-4.1] vs. 3.1/hour [95% CI: 2.9-3.4]). Men recorded higher maximum single-impact peak linear acceleration (PLA; median 31 g vs. women: median 22 g; p < 0.001) and peak rotational acceleration (PRA; median 3.0 krad/s² vs. women: 2.4 krad/s²; p < 0.001) per match. Conversely, women experienced greater PRA per impact (median 1.4 krad/s² vs. men: 1.2 krad/s²; p < 0.001), while PLA was similar (men: median 14 g, women: median 13 g; p = 0.330). The leading match events resulting in HAEs were marking contests (1.0/hour) in men and contested ball situations (0.8/hour) in women. HAE incidence and magnitude were generally comparable across playing positions, except for men's rucks, who experienced significantly higher incidence of HAEs (6.5/hour) than forwards (3.6/hour), midfielders (3.2/hour), and defenders (2.7/hour). This study highlights differences in HAE incidence, magnitude, and mechanisms by sex, playing position, and match events in elite-level Australian Rules football. These findings provide insight into impact exposure patterns and may inform targeted skill development and policy adjustments to enhance player safety.
- 16 February 2026
- Published by Springer Nature in Sports Medicine - Open
- Vol. 12 (1) , 11
Open AccessHead Acceleration Events Measured by Instrumented Mouthguards in Elite Australian Football
The consequences of exposure to head acceleration events (HAEs) in collision sports, including Australian Rules football, are a growing concern. Instrumented mouthguards (iMGs) now enable accurate quantification of HAEs in sport; however, little is known about HAE incidence and mechanisms in Australian Rules football. We aimed to measure HAEs in elite Australian Rules football players, and evaluate the influence of playing position and match event on the incidence and magnitude of HAEs in men and women. iMG data were collected from Australian Football League (AFL) and AFL Women's (AFLW) players in 2023 utilising the HIT-IQ Nexus Gen III iMG, targeting 500 player-matches per sex. Match footage was synchronised with iMG data for video verification and match play coding. Three hundred and eleven players contributed iMG data in the analyses, including 126 men (median matches per player: 3 (interquartile range [IQR: 2-6]) and 185 women (median: 3 [IQR: 1-4]). Men had a higher mean incidence of HAEs ≥ 8 g per match than women (5.7 [95% confidence interval CI: 5.0-6.4] vs. 3.0 [95% CI: 2.8-3.3]), however the incidence was comparable when adjusted for time (3.6/hour [95% CI: 3.2-4.1] vs. 3.1/hour [95% CI: 2.9-3.4]). Men recorded higher maximum single-impact peak linear acceleration (PLA; median 31 g vs. women: median 22 g; p < 0.001) and peak rotational acceleration (PRA; median 3.0 krad/s² vs. women: 2.4 krad/s²; p < 0.001) per match. Conversely, women experienced greater PRA per impact (median 1.4 krad/s² vs. men: 1.2 krad/s²; p < 0.001), while PLA was similar (men: median 14 g, women: median 13 g; p = 0.330). The leading match events resulting in HAEs were marking contests (1.0/hour) in men and contested ball situations (0.8/hour) in women. HAE incidence and magnitude were generally comparable across playing positions, except for men's rucks, who experienced significantly higher incidence of HAEs (6.5/hour) than forwards (3.6/hour), midfielders (3.2/hour), and defenders (2.7/hour). This study highlights differences in HAE incidence, magnitude, and mechanisms by sex, playing position, and match events in elite-level Australian Rules football. These findings provide insight into impact exposure patterns and may inform targeted skill development and policy adjustments to enhance player safety.
- 11 March 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (5) , e210308
Next-Day Serum Glial Fibrillary Acidic Protein Levels to Aid Diagnosis of Sport-Related Concussion
Previous studies on sport-related concussion (SRC) may have measured brain injury blood-based biomarker, glial fibrillary acidic protein (GFAP), either before or after its peak, potentially underestimating the diagnostic value. The primary aim of this study was to evaluate the diagnostic performance of serum GFAP at 24 hours post-SRC. Secondary objectives included assessing whether the timing of sample collection relative to an Australian football match (with or without SRC) affected GFAP levels, evaluating if combining GFAP with symptoms improved discrimination of SRC compared with symptoms alone, and determining the diagnostic utility of serum neurofilament light (NfL) levels at 24 hours post-SRC. In a prospective cohort study, adult male and female Australian football players of the Victorian Amateur Football Association (Melbourne, Australia) with and without SRC had blood sampled around 24 hours postinjury/postmatch. GFAP and NfL levels were quantified using Simoa assays, and area under the curve (AUC) values were calculated for time bins of 16-24 hours, 24-32 hours, and 36-52 hours. Symptom severity at blood collection was assessed using the Sport Concussion Assessment Tool 5 (SCAT). A total of 151 athletes with SRC (median age 22.5 years; 85% male) and 97 controls (median age 24.3 years; 86% male) were sampled at a median of 24.5 hours (interquartile range [IQR] 21.7-28.0; min-max 16-51.5). Time to sample postmatch did not affect GFAP levels in controls; however, higher GFAP levels correlated with shorter time post-SRC (Spearman r = -0.25, 95% CI -0.40 to -0.09). Median GFAP concentrations were 65.9 pg/mL (IQR 49.1-81.3) in controls, and for SRC, 124.6 pg/mL (IQR 86.7-190.7) at 16-24 hours, 94.5 pg/mL (IQR 61.6-163.9) at 24-32 hours, and 59.9 pg/mL (IQR 49.1-94.7) at 36-52 hours. AUC values at 16-24 and 24-32 hours were 0.83 (95% CI 0.76-0.90) and 0.72 (95% CI 0.64-0.80), respectively. Furthermore, combining GFAP with SCAT symptoms at 16-24 hours enhanced discriminatory capability compared with SCAT symptoms alone (AUC increased from 0.91 to 0.97; z = 2.48, p = 0.01). Serum NfL had a limited diagnostic value (AUC ≤0.60). Serum GFAP measured at 16-24 hours following potential or suspected SRC may be a useful objective aid to SRC diagnosis.
- 11 March 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (5) , e210308
Next-Day Serum Glial Fibrillary Acidic Protein Levels to Aid Diagnosis of Sport-Related Concussion
Previous studies on sport-related concussion (SRC) may have measured brain injury blood-based biomarker, glial fibrillary acidic protein (GFAP), either before or after its peak, potentially underestimating the diagnostic value. The primary aim of this study was to evaluate the diagnostic performance of serum GFAP at 24 hours post-SRC. Secondary objectives included assessing whether the timing of sample collection relative to an Australian football match (with or without SRC) affected GFAP levels, evaluating if combining GFAP with symptoms improved discrimination of SRC compared with symptoms alone, and determining the diagnostic utility of serum neurofilament light (NfL) levels at 24 hours post-SRC. In a prospective cohort study, adult male and female Australian football players of the Victorian Amateur Football Association (Melbourne, Australia) with and without SRC had blood sampled around 24 hours postinjury/postmatch. GFAP and NfL levels were quantified using Simoa assays, and area under the curve (AUC) values were calculated for time bins of 16-24 hours, 24-32 hours, and 36-52 hours. Symptom severity at blood collection was assessed using the Sport Concussion Assessment Tool 5 (SCAT). A total of 151 athletes with SRC (median age 22.5 years; 85% male) and 97 controls (median age 24.3 years; 86% male) were sampled at a median of 24.5 hours (interquartile range [IQR] 21.7-28.0; min-max 16-51.5). Time to sample postmatch did not affect GFAP levels in controls; however, higher GFAP levels correlated with shorter time post-SRC (Spearman r = -0.25, 95% CI -0.40 to -0.09). Median GFAP concentrations were 65.9 pg/mL (IQR 49.1-81.3) in controls, and for SRC, 124.6 pg/mL (IQR 86.7-190.7) at 16-24 hours, 94.5 pg/mL (IQR 61.6-163.9) at 24-32 hours, and 59.9 pg/mL (IQR 49.1-94.7) at 36-52 hours. AUC values at 16-24 and 24-32 hours were 0.83 (95% CI 0.76-0.90) and 0.72 (95% CI 0.64-0.80), respectively. Furthermore, combining GFAP with SCAT symptoms at 16-24 hours enhanced discriminatory capability compared with SCAT symptoms alone (AUC increased from 0.91 to 0.97; z = 2.48, p = 0.01). Serum NfL had a limited diagnostic value (AUC ≤0.60). Serum GFAP measured at 16-24 hours following potential or suspected SRC may be a useful objective aid to SRC diagnosis.
- Open Access
- 19 November 2024
- Published by Springer Nature in Sports Medicine
- Vol. 55 (4) , 1037-1049
Associations Between Instrumented Mouthguard-Measured Head Acceleration Events and Post-Match Biomarkers of Astroglial and Axonal Injury in Male Amateur Australian Football Players
Background: Advances in instrumented mouthguards (iMGs) allow for accurate quantification of single high-acceleration head impacts and cumulative head acceleration exposure in collision sports. However, relationships between these measures and risk of brain cell injury remain unclear. Aim: The purpose of this study was to quantify measures of non-concussive head impact exposure and assess their association with blood glial fibrillary acidic protein (GFAP), neurofilament light (NfL) and phosphorylated-tau-181 (p-tau-181) levels in male Australian football players. Methods: A total of 31 athletes underwent in-season (24 h post-match) and post-season (> 5 weeks) blood collections and/or wore HITIQ Nexus A9 iMGs measuring peak linear (PLA) and rotational (PRA) acceleration. Match footage was used to verify and code impacts. Blood GFAP, NfL, and p-tau-181 were quantified using Simoa and natural log transformed for analysis. Associations between post-match biomarkers and within match maximum single impact and cumulative PLA/PRA were assessed with linear mixed models. Results: In-season versus post-season elevations were found for GFAP (mean difference 0.14, 95% CI 0.01–0.26, p = 0.033), NfL (mean difference = 0.21, 95% CI 0.09–0.32, p = 0.001) and p-tau-181 (mean difference = 0.49, 95% CI 0.33–0.65, p < 0.001). Post-match GFAP was associated with maximum single impact PLA (B = 0.003, 95% CI 0.0002–0.005, p = 0.036), cumulative PLA (B = 0.001, 95% CI 0.0002–0.002, p = 0.017), cumulative PRA (B = 0.01, 95% CI 0.002–0.02, p = 0.014), and impact number (B = 0.03, 95% CI 0.003–0.05, p = 0.029) within a single match. Change in NfL levels between two-matches correlated with cumulative PLA (r = 0.80, 95% CI 0.38–0.95, p = 0.005), PRA (r = 0.71, 95% CI 0.19–0.92, p = 0.019) and impact number (r = 0.63, 95% CI 0.05–0.89, p = 0.038). Conclusion: Maximum and cumulative head accelerations in Australian football, measured by iMGs, were associated with elevated blood biomarkers of brain injury, highlighting the potential of both technologies for head impact management in collision sports.
- 19 November 2024
- Published by Springer Nature in Sports Medicine
- Vol. 55 (4) , 1037-1049
Open AccessAssociations Between Instrumented Mouthguard-Measured Head Acceleration Events and Post-Match Biomarkers of Astroglial and Axonal Injury in Male Amateur Australian Football Players
Background: Advances in instrumented mouthguards (iMGs) allow for accurate quantification of single high-acceleration head impacts and cumulative head acceleration exposure in collision sports. However, relationships between these measures and risk of brain cell injury remain unclear. Aim: The purpose of this study was to quantify measures of non-concussive head impact exposure and assess their association with blood glial fibrillary acidic protein (GFAP), neurofilament light (NfL) and phosphorylated-tau-181 (p-tau-181) levels in male Australian football players. Methods: A total of 31 athletes underwent in-season (24 h post-match) and post-season (> 5 weeks) blood collections and/or wore HITIQ Nexus A9 iMGs measuring peak linear (PLA) and rotational (PRA) acceleration. Match footage was used to verify and code impacts. Blood GFAP, NfL, and p-tau-181 were quantified using Simoa and natural log transformed for analysis. Associations between post-match biomarkers and within match maximum single impact and cumulative PLA/PRA were assessed with linear mixed models. Results: In-season versus post-season elevations were found for GFAP (mean difference 0.14, 95% CI 0.01–0.26, p = 0.033), NfL (mean difference = 0.21, 95% CI 0.09–0.32, p = 0.001) and p-tau-181 (mean difference = 0.49, 95% CI 0.33–0.65, p < 0.001). Post-match GFAP was associated with maximum single impact PLA (B = 0.003, 95% CI 0.0002–0.005, p = 0.036), cumulative PLA (B = 0.001, 95% CI 0.0002–0.002, p = 0.017), cumulative PRA (B = 0.01, 95% CI 0.002–0.02, p = 0.014), and impact number (B = 0.03, 95% CI 0.003–0.05, p = 0.029) within a single match. Change in NfL levels between two-matches correlated with cumulative PLA (r = 0.80, 95% CI 0.38–0.95, p = 0.005), PRA (r = 0.71, 95% CI 0.19–0.92, p = 0.019) and impact number (r = 0.63, 95% CI 0.05–0.89, p = 0.038). Conclusion: Maximum and cumulative head accelerations in Australian football, measured by iMGs, were associated with elevated blood biomarkers of brain injury, highlighting the potential of both technologies for head impact management in collision sports.